XNAS: INKT
MiNK Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The co...
Read More
9.46
-0.11
(-1.15%)
61,049.8
XNAS Volume
XNAS 18 Mar, 2026 4:12 PM (EDT)
Board Meeting
The board meeting for MiNK Therapeutics Inc is scheduled for today, for the purpose of MiNK Therapeutics Inc Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
MiNK Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..